Identification and use of prognostic and predictive markers in cancer treatment

Details for Australian Patent Application No. 2005316534 (hide)

Owner NSABP Foundation, Inc.

Inventors Paik, Soonmyung; Kim, Chungyeul

Agent Spruson & Ferguson

Pub. Number AU-A-2005316534

PCT Pub. Number WO2006/065940

Priority 60/698,112 11.07.05 US; 60/636,169 15.12.04 US; 60/717,485 14.09.05 US

Filing date 15 December 2005

Wipo publication date 22 June 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065940 Priority application(s): WO2006/065940

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316535-Carrier and method

2005316532-Cancer-specific SPANX-N markers